Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by F-star Therapeutics, Inc. F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies July 05, 2023 From F-star Therapeutics, Inc. Via GlobeNewswire F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma March 07, 2023 From F-star Therapeutics, Inc. Via GlobeNewswire Tickers FSTX invoX Pharma and F-star Therapeutics issue Joint Statement January 26, 2023 From F-star Therapeutics, Inc. Via GlobeNewswire Tickers FSTX F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress December 06, 2022 From F-star Therapeutics, Inc. Via GlobeNewswire Tickers FSTX F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research November 07, 2022 From F-star Therapeutics, Inc. Via GlobeNewswire Tickers FSTX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.